AR002283A1 - Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas. - Google Patents
Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas.Info
- Publication number
- AR002283A1 AR002283A1 ARP960101766A AR10176696A AR002283A1 AR 002283 A1 AR002283 A1 AR 002283A1 AR P960101766 A ARP960101766 A AR P960101766A AR 10176696 A AR10176696 A AR 10176696A AR 002283 A1 AR002283 A1 AR 002283A1
- Authority
- AR
- Argentina
- Prior art keywords
- therapy
- women
- premonopausic
- perimenopausic
- hormones
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se propone un preparado hormonal de acción anticonceptiva que a la vez sirve para la terapia de reemplazo de hormonas en mujeres perimenopáusicas ypremenopáusicas. Los medicamentos conocidos para este último fin no son eficaces como anticonceptivos. Para resolver este problema, el preparado delinvento contiene en calidad de sustancias activas un componente estrógeno natural (sin etinilestradiol) y un componente gestágeno. Con estemedicamento se logra una acción anticonceptivasegura junto con una terapia eficaz de las primeras manifestaciones de falta de estrógenos y la prevenciónde la osteoporosis.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19510861A DE19510861A1 (de) | 1995-03-16 | 1995-03-16 | Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR002283A1 true AR002283A1 (es) | 1998-03-11 |
Family
ID=7757668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960101766A AR002283A1 (es) | 1995-03-16 | 1996-03-15 | Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0814811A1 (es) |
| JP (1) | JPH11501649A (es) |
| KR (1) | KR19980703058A (es) |
| AR (1) | AR002283A1 (es) |
| AU (1) | AU713258B2 (es) |
| CA (1) | CA2215382A1 (es) |
| CZ (1) | CZ289697A3 (es) |
| DE (1) | DE19510861A1 (es) |
| HU (1) | HUP9801691A3 (es) |
| IL (1) | IL117516A (es) |
| MX (1) | MX9707009A (es) |
| NO (1) | NO974255L (es) |
| NZ (1) | NZ304027A (es) |
| PL (1) | PL322202A1 (es) |
| SK (1) | SK123997A3 (es) |
| WO (1) | WO1996028165A1 (es) |
| ZA (1) | ZA962177B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
| KR20250142811A (ko) * | 2024-03-22 | 2025-09-30 | 주식회사 에아스텍 | 노르에티스테론 에난테이트 화합물의 암의 예방 또는 치료 용도 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
-
1995
- 1995-03-16 DE DE19510861A patent/DE19510861A1/de not_active Withdrawn
-
1996
- 1996-03-15 JP JP8527295A patent/JPH11501649A/ja not_active Ceased
- 1996-03-15 HU HU9801691A patent/HUP9801691A3/hu unknown
- 1996-03-15 WO PCT/EP1996/001201 patent/WO1996028165A1/de not_active Ceased
- 1996-03-15 CA CA002215382A patent/CA2215382A1/en not_active Abandoned
- 1996-03-15 CZ CZ972896A patent/CZ289697A3/cs unknown
- 1996-03-15 PL PL96322202A patent/PL322202A1/xx unknown
- 1996-03-15 SK SK1239-97A patent/SK123997A3/sk unknown
- 1996-03-15 AR ARP960101766A patent/AR002283A1/es unknown
- 1996-03-15 NZ NZ304027A patent/NZ304027A/xx not_active IP Right Cessation
- 1996-03-15 EP EP96907506A patent/EP0814811A1/de not_active Withdrawn
- 1996-03-15 KR KR1019970706467A patent/KR19980703058A/ko not_active Ceased
- 1996-03-15 MX MX9707009A patent/MX9707009A/es not_active IP Right Cessation
- 1996-03-15 AU AU51108/96A patent/AU713258B2/en not_active Ceased
- 1996-03-17 IL IL11751696A patent/IL117516A/xx not_active IP Right Cessation
- 1996-03-18 ZA ZA962177A patent/ZA962177B/xx unknown
-
1997
- 1997-09-15 NO NO974255A patent/NO974255L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR19980703058A (ko) | 1998-09-05 |
| JPH11501649A (ja) | 1999-02-09 |
| DE19510861A1 (de) | 1996-09-19 |
| CZ289697A3 (en) | 1997-12-17 |
| NZ304027A (en) | 2000-05-26 |
| IL117516A (en) | 2000-07-26 |
| WO1996028165A1 (de) | 1996-09-19 |
| CA2215382A1 (en) | 1996-09-19 |
| HUP9801691A2 (hu) | 1998-11-30 |
| IL117516A0 (en) | 1996-07-23 |
| NO974255L (no) | 1997-11-14 |
| NO974255D0 (no) | 1997-09-15 |
| AU5110896A (en) | 1996-10-02 |
| HUP9801691A3 (en) | 1999-03-01 |
| AU713258B2 (en) | 1999-11-25 |
| MX9707009A (es) | 1997-11-29 |
| PL322202A1 (en) | 1998-01-19 |
| ZA962177B (en) | 1996-07-29 |
| SK123997A3 (en) | 1998-02-04 |
| EP0814811A1 (de) | 1998-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR960706344A (ko) | 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne) | |
| KR960700727A (ko) | 호르몬 대체 치료(hormone replacement therapy) | |
| DK0836506T4 (da) | Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen | |
| HRP20070188B1 (hr) | Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva | |
| BR9709934A (pt) | Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga | |
| YU54602A (sh) | Drospirenon za terapiju zamene hormona | |
| RU95118436A (ru) | Гормональная заместительная терапия | |
| PT835114E (pt) | Preparado de combinacao farmaceutico kit e metodo para contracepcao hormonal | |
| KR920011514A (ko) | 프로게스토겐만을 함유하는 피임제 | |
| CA2468748A1 (en) | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | |
| NO327588B1 (no) | Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel | |
| AR009113A1 (es) | UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA | |
| AR002283A1 (es) | Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas. | |
| MX2024009584A (es) | Metodos anticonceptivos con efectos de sangrado programado. | |
| BR9708162A (pt) | Combinação de antagonista estrogênio/progesterona sequencial para a terapia de substituição hormonal | |
| AR025443A1 (es) | Una composicion farmaceutica para ser usada como anticonceptivo. | |
| BR9912260A (pt) | Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração | |
| Diczfalusy | Improved long-acting fertility regulating agents: What are the problems? | |
| DOP2006000035A (es) | Preparación farmaceútica para la anticoncepción oral | |
| GB1116795A (en) | An oral contraceptive preparation | |
| AR035633A1 (es) | Drospirenona para terapia de reemplazo de hormonas | |
| TH39540A (th) | สารผสมที่ฉีดได้เดือนละครั้ง ซึ่งเป็นยาคุมกำเนิดดีพอท และสำหรับรักษาโรคโดยการแทนชอร์โมนสำหรับผู้หญิงวัยใกล้หมดประจำเดือนและวัยก่อนหมดประจำเดือน | |
| HRP20020666B1 (hr) | Drospirenon za hormonsku nadomjesnu terapiju | |
| TH27339A (th) | ฮอร์โมนตัวใหม่ที่ใช้เป็นยาและประโยชน์ของมันในการรักษาภาวะขาดเอสโตเจน | |
| UY26539A1 (es) | Drospirenona para terapia de reemplazo de hormonas. |